InvestorsHub Logo
Followers 375
Posts 16984
Boards Moderated 4
Alias Born 03/07/2014

Re: interstate post# 80622

Thursday, 01/29/2015 12:38:08 PM

Thursday, January 29, 2015 12:38:08 PM

Post# of 92948
"Doesn't REGENERON PHARMACEUTICALS COM REGN: NASDAQ have an approved stem cell treatment on the market?"??

I have no idea if they claim to or not? But according to the U.S. Govt FDA website- "hemacord" and "cordblood" a few products related to that- are THEE ONLY "stem cell" FDA approved anything. That's right off the FDA website and using their own words, not mine.

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm286155.htm

"FDA has approved only one stem cell product, Hemacord, a cord blood-derived product manufactured by the New York Blood Center and used for specified indications in patients with disorders affecting the body’s blood-forming system."


Everything the FDA has to say about "stem cell" anything (treatments, cures, products, whatever) is pretty much covered on that portion of their website IMO. No ambiguity that I can see?

Pretty clear cut.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.